Jun N terminal kinase inhibitors (Imago)

N/A

Report date: 2025/01/26 15:09:18
NME

Base Information

Drug NameJun N terminal kinase inhibitors (Imago)
Drug Alias NameSMA program (Imago Pharmaceuticals)JNK inhibitors (Imago)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImago Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesImago Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMuscular Atrophy, Spinal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A